Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Magnesium Sulphate in Status Asthmaticus
NCT04929626Phase 1Completed
- Sponsor
- Ziauddin University
- Start
- Jan 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of magnesium sulfate in status asthmaticus (2 arms), sponsored by Ziauddin University. Primary endpoints: Change in Pediatric Respiratory Assessment Measure (PRAM) score from baseline, Change from baseline Suprasternal indrawing and 4 more. Started Jan 2022; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
status asthmaticus
Beyond the preview
Go deeper on NCT04929626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04929626.